<DOC>
	<DOCNO>NCT01541319</DOCNO>
	<brief_summary>A large multicenter randomize control trial approximately 1700 critically ill patient ' status post complex cardiac surgery sternotomy , call Red Cell Storage Duration Study ( RECESS ) , currently ongoing . In RECESS trial , study group randomize either RBCs less equal 10 day storage time great equal 21 day . The primary outcome RECESS change multiple organ dysfunction score . Secondary outcome RECESS include cause 28-day mortality , mechanical ventilation free day , clinical outcome . The RECESS study present unique opportunity investigate mechanism associate RBC storage duration context clinical outcome well-characterized surgical study group . The ancillary study describe call Mechanism Repository Study ( MARS ) RECESS . The MARS study analyze commonly report hypothesized mechanism consider associated RBC storage lesion adverse outcome critically ill patient . Laboratories expertise RBC function , nitric oxide mechanism , coagulation cascade , microparticle analysis immunology examine hypotheses address mechanism potentially able relate storage time clinical outcome RBC transfusion recipient . At conclusion study , result provide much good understand RBC storage age affect recipient RBC function , coagulation parameter , microparticle load immune modulation . Perhaps importantly , study also develop large sample repository future analysis .</brief_summary>
	<brief_title>Mechanism Repository Study Red Cell Storage Duration Study</brief_title>
	<detailed_description>MARS enroll approximately 250 subject participate RECESS study , additional 50 healthy volunteer . The RECESS subject participate MARS blood drawn cardiac surgery , 2 day cardiac surgery . If receive red blood cell ( RBC ) transfusion surgery 96 hour follow end surgery , also blood drawn approximately 6 day , 28 day , 180 day surgery , answer health questionnaire 28-day 180-day visit . The healthy volunteer participate MARS single blood draw . All MARS subject blood sample send repository future study . A subset RECESS subject participate MARS , healthy volunteer participate MARS , also number laboratory test perform part MARS study . These test include 1. laboratory measure vascular signaling , include NO content , NO disposition ; oxidative modification RBC membrane thiols ; flux vasoactive S-nitrosothiols ( RSNOs ) . 2. laboratory measure coagulation , include thrombin generation ; prothrombin fragment 1+2 , fibrinopeptide A ; soluble thrombomodulin , protein C , PAI-1 , tissue plasminogen activator , Factor V , Factor VII , Factor VIII , D-Dimer , antithrombin III , soluble endothelial protein C receptor , TFPI , Xia , INR , PT , PTT ( use standard test method ) ; clot formation measure rotation thrombo-elastometry . 3. laboratory measure microparticle count , include CD3 ( T cell ) , CD66b ( Granulocytes ) , CD 14 ( Monocytes ) , CD42a ( Platelets ) , CD235a ( RBCs ) , CD41a ( Platelets ) , CD44 ( Surface glycoprotein ) , CD35 ( Complement receptor1 ) , CD108 ( Semaphorin 7A ) , Annexin V , CD154 ( CD40-ligand ) , CD62p ( p-selectin ) , CD59 ( Protectin ) , CD55 ( complement DAF ) , CD58 ( LFA-3 ) . 4. laboratory measure inflammation immune function , include regulatory T cell , Th17 cell , MMP-9 , MPO , Pi-1 ( total ) , sE-Selectin , sICAM-1 , sVCAM-1 , IL-1β , IL-2 , IL-4 , IL-5 , IL-6 , IL-7 , IL-8 , IL-10 , IL-12 ( p70 ) , IL-13 , IFN-γ , GM-CSF , TNF-α . At one hospital , sample RBC unit transfuse MARS subject also analyze nitric oxide parameter . The primary objective MARS compare post-operative value laboratory parameter RBC-transfused RECESS subject randomize receive RBCs store 10 day less RBC-transfused RECESS subject randomize receive RBCs store 21 day . Secondary objective include 1 . Determining whether value laboratory parameter associate clinical outcome among RECESS participant , include change multi-organ dysfunction score ( MODS ) pre-surgery death , hospital discharge , post-operative day 7 ( whichever occurs first ) ; change MODS pre-surgery death , hospital discharge , post-operative day 28 ( whichever occurs first ) ; all-cause mortality . 2 . Determining whether correlation laboratory parameter RECESS subject time point ( pre-surgery post-operative day 2 , 6 , 180 ) . 3 . Comparing change laboratory parameter pre-surgery Day 2 randomize RECESS subject undergo surgery receive RBC transfusion versus randomize treatment group receive RBC transfusion . 4 . Comparing value laboratory parameter healthy volunteer pre-surgery value RECESS subject schedule undergo cardiac surgery . 5 . Assessing nitric oxide parameter RBC unit differ depend storage duration unit . 6 . Assessing post-transfusion nitric oxide parameter transfuse subject differ depend pre-transfusion nitric oxide parameter parameter transfuse unit .</detailed_description>
	<criteria>Inclusion Criteria RECESS subject participate MARS : 1 . Randomized Red Cell Storage Duration Study ( RECESS ) 2 . Patients ≥ 18 year old Exclusion Criteria RECESS subject participate MARS : There exclusion criterion . Inclusion Criteria healthy volunteer participate MARS : 1 . At least 18 year old 2 . In generally good health Exclusion Criteria healthy volunteer participate MARS : 1 . History red blood cell transfusion within previous 6 month . 2 . History surgery within previous 6 month . 3 . Currently treat inhale nitric oxide , nitroglycerin form , nitroprusside . 4 . Currently treat prednisone , corticosteroid , cyclosporine , chemotherapy , remicade , methotrexate , Enbrel and/or antibody base therapy modulate immune system . 5 . Currently treat heparin anticoagulant ( example coumadin , pradaxa , low molecular weight heparin ) . 6 . Received nonsteroidal antiinflammatory drug within previous 24 hour . 7 . Received aspirin within previous 5 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Erythrocyte Transfusion</keyword>
</DOC>